CCR5 and triple-negative breast carcinoma: High expression of CXCR4 or CCR5 on tumor was found to be associated with poor prognosis, and CXCR5 on tumor was associated with poor chemotherapy response in the present cohort with locally advanced triple-negative breast cancer.